Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized Phase III Trial Comparing Conventional-Dose Chemotherapy Using Paclitaxel, Ifosfamide, and Cisplatin (TIP) with High-Dose Chemotherapy Using Mobilizing Paclitaxel Plus Ifosfamide Followed by High-Dose Carboplatin and Etoposide (TI-CE) As First Salvage Treatment in Relapsed or Refractory Germ Cell Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02375204
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:26:58.885037+00:00
Published At
2025-01-13T00:00:00+00:00
Record Updated At
2025-01-13
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Germ Cell Tumor", "Teratoma", "Choriocarcinoma", "Germinoma", "Mixed Germ Cell Tumor", "Yolk Sac Tumor", "Childhood Teratoma", "Malignant Germ Cell Neoplasm", "Extragonadal Seminoma", "Non-seminomatous Germ Cell Tumor", "Seminoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-01-13"
protocolSection.identificationModule.nctId
"NCT02375204"
protocolSection.identificationModule.officialTitle
"A Randomized Phase III Trial Comparing Conventional-Dose Chemotherapy Using Paclitaxel, Ifosfamide, and Cisplatin (TIP) with High-Dose Chemotherapy Using Mobilizing Paclitaxel Plus Ifosfamide Followed by High-Dose Carboplatin and Etoposide (TI-CE) As First Salvage Treatment in Relapsed or Refractory Germ Cell Tumors"
protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Germ Cell Tumor (protocolSection.conditionsModule.conditions)
  • Teratoma (protocolSection.conditionsModule.conditions)
  • Choriocarcinoma (protocolSection.conditionsModule.conditions)
  • Germinoma (protocolSection.conditionsModule.conditions)
  • Mixed Germ Cell Tumor (protocolSection.conditionsModule.conditions)
  • Yolk Sac Tumor (protocolSection.conditionsModule.conditions)
  • Childhood Teratoma (protocolSection.conditionsModule.conditions)
  • Malignant Germ Cell Neoplasm (protocolSection.conditionsModule.conditions)
  • Extragonadal Seminoma (protocolSection.conditionsModule.conditions)
  • Non-seminomatous Germ Cell Tumor (protocolSection.conditionsModule.conditions)
  • Seminoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.